Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Immobilized Biotinylated Human CD39 (R138A, M139A, E142K) Protein, His,Avitag (Cat. No. CD9-H82E8) at 1 μg/mL (100 μL/well)on streptavidin precoated (Cat. No. STN-N5116) (0.5 μg/well) plate can bind Anti-CD39 Antibody, Human IgG1 with a linear range of 0.1-4 ng/mL (QC tested).
The purity of Cynomolgus CD39 Protein, His Tag (Cat. No. CD9-C5PH3) is more than 85% and the molecular weight of this protein is around 65-85 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
TTX-030 | TTX-030 | Phase 2 Clinical | Adimab LLC | Solid tumours; Pancreatic Neoplasms; Lymphoma | Details |
IPH-5201 | IPH-5201 | Phase 2 Clinical | Inserm, Orega Biotech | Solid tumours; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
Perenostobart | SRF-617 | Phase 2 Clinical | Surface Oncology Inc | Solid tumours; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details |
JS-019 | JS-019 | Phase 1 Clinical | Beijing Enrini Biotechnology Co Ltd | Solid tumours; Lymphoma | Details |
ES-014 | ES-014 | Phase 1 Clinical | Elpiscience (Shanghai) Biopharma Ltd | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |
PUR-001 | PUR-001 | Phase 1 Clinical | Purinomia Biotech Inc | Solid tumours | Details |
AB-598 | AB598 | Phase 1 Clinical | Arcus Biosciences Inc | Ovarian Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | Details |
Eurestobart | ES-002023 | Phase 1 Clinical | Elpiscience (Shanghai) Biopharma Ltd | Solid tumours | Details |
ES-002 | ES-002 | Phase 1 Clinical | Elpiscience (Shanghai) Biopharma Ltd | Solid tumours; Neoplasms | Details |
TTX-030 | TTX-030 | Phase 2 Clinical | Adimab LLC | Solid tumours; Pancreatic Neoplasms; Lymphoma | Details |
IPH-5201 | IPH-5201 | Phase 2 Clinical | Inserm, Orega Biotech | Solid tumours; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
Perenostobart | SRF-617 | Phase 2 Clinical | Surface Oncology Inc | Solid tumours; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details |
JS-019 | JS-019 | Phase 1 Clinical | Beijing Enrini Biotechnology Co Ltd | Solid tumours; Lymphoma | Details |
ES-014 | ES-014 | Phase 1 Clinical | Elpiscience (Shanghai) Biopharma Ltd | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |
PUR-001 | PUR-001 | Phase 1 Clinical | Purinomia Biotech Inc | Solid tumours | Details |
AB-598 | AB598 | Phase 1 Clinical | Arcus Biosciences Inc | Ovarian Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | Details |
Eurestobart | ES-002023 | Phase 1 Clinical | Elpiscience (Shanghai) Biopharma Ltd | Solid tumours | Details |
ES-002 | ES-002 | Phase 1 Clinical | Elpiscience (Shanghai) Biopharma Ltd | Solid tumours; Neoplasms | Details |
This web search service is supported by Google Inc.